The vaccinia virus N1L protein is an intracellular homodimer that promotes virulence

被引:106
作者
Bartlett, N
Symons, JA
Tscharke, DC
Smith, GL
机构
[1] Univ London Imperial Coll Sci Technol & Med, Fac Med, Wright Fleming Inst, Dept Virol, London W2 1PG, England
[2] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England
关键词
D O I
10.1099/0022-1317-83-8-1965
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The vaccinia virus (VV) N1L gene encodes a protein of 14 kDa that was identified previously in the concentrated supernatant of virus-infected cells. Here we show that the protein is present predominantly (> 90%) within cells rather than in the culture supernatant and it exists as a nonglycosylated, non-covalent homodimer. The N1L protein present in the culture supernatant was uncleaved at the N terminus and was released from cells more slowly than the VV A41L gene product, a secreted glycoprotein that has a conventional signal peptide. Bioinformatic analyses predict that the N 1 L protein is largely alpha-helical and show that it is conserved in many VV strains, in other orthopoxviruses and in members of other chordopoxvirus genera. However, database searches found no non-poxvirus proteins with significant amino acid similarity to N 1 L. A deletion mutant lacking the N I L gene replicated normally in cell culture, but was attenuated in intranasal and intradermal murine models compared to wild-type and revertant controls. The conservation of the N I L protein and the attenuated phenotype of the deletion mutant indicate an important role in the virus life-cycle.
引用
收藏
页码:1965 / 1976
页数:12
相关论文
共 39 条
  • [1] Viral mechanisms of immune evasion
    Alcami, A
    Koszinowski, UH
    [J]. TRENDS IN MICROBIOLOGY, 2000, 8 (09) : 410 - 418
  • [2] ALCAMI A, 1995, J VIROL, V69, P4633
  • [3] A SOLUBLE RECEPTOR FOR INTERLEUKIN-1-BETA ENCODED BY VACCINIA VIRUS - A NOVEL MECHANISM OF VIRUS MODULATION OF THE HOST RESPONSE TO INFECTION
    ALCAMI, A
    SMITH, GL
    [J]. CELL, 1992, 71 (01) : 153 - 167
  • [4] Alcamí A, 1998, J IMMUNOL, V160, P624
  • [5] The complete genomic sequence of the modified vaccinia Ankara strain: Comparison with other orthopoxviruses
    Antoine, G
    Scheiflinger, F
    Dorner, F
    Falkner, FG
    [J]. VIROLOGY, 1998, 244 (02) : 365 - 396
  • [6] A DOMINANT SELECTABLE MARKER FOR THE CONSTRUCTION OF RECOMBINANT POXVIRUSES
    BOYLE, DB
    COUPAR, BEH
    [J]. GENE, 1988, 65 (01) : 123 - 128
  • [7] DECREASED VIRULENCE OF RECOMBINANT VACCINIA VIRUS EXPRESSION VECTORS IS ASSOCIATED WITH A THYMIDINE KINASE-NEGATIVE PHENOTYPE
    BULLER, RML
    SMITH, GL
    CREMER, K
    NOTKINS, AL
    MOSS, B
    [J]. NATURE, 1985, 317 (6040) : 813 - 815
  • [8] The complete DNA sequence of myxoma virus
    Cameron, C
    Hota-Mitchell, S
    Chen, L
    Barrett, J
    Cao, JX
    Macaulay, C
    Willer, D
    Evans, D
    McFadden, G
    [J]. VIROLOGY, 1999, 264 (02) : 298 - 318
  • [9] ATTENUATED DELETION MUTANT OF VACCINIA VIRUS IHD-W RECOVERED VIRULENCE BY REINSERTION OF A TERMINAL RESTRICTION FRAGMENT
    CHANG, PY
    LAI, ACK
    POGO, BGT
    [J]. MICROBIAL PATHOGENESIS, 1992, 13 (01) : 49 - 59
  • [10] TRANSIENT DOMINANT SELECTION OF RECOMBINANT VACCINIA VIRUSES
    FALKNER, FG
    MOSS, B
    [J]. JOURNAL OF VIROLOGY, 1990, 64 (06) : 3108 - 3111